BioSyent, Inc. (RX.V)
12.05
+0.23
(+1.95%)
CAD |
TSXV |
Dec 11, 16:00
BioSyent Total Liabilities (Quarterly): 7.882M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biocure Technology, Inc. | 0.4131M |
| Core One Labs, Inc. | -- |
| Restart Life Sciences Corp. | 0.3016M |
| NanoSphere Health Sciences, Inc. | 1.932M |
| Lobe Sciences Ltd. | 4.623M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 47.79M |
| Shareholders Equity (Quarterly) | 39.90M |
| Debt to Equity Ratio | 0.0224 |
| Current Ratio | 5.061 |
| Net Debt Paydown Yield | 0.04% |